Replies to post #121828 on Amarantus Bioscience Holdings Inc (AMBS)

[christjamin]

Thank you buddy, I really appreciate your DD. Keep up the good word, but refrain from deception and distortion. Lool.. It will just help you, Trust me on that. By the way, are you aware of these two ones: AV*l and GB*N. May be they are worth a look. The former has business deal with AMBS on Lympro, with promising results on Alzheimer. The latter just finished conversion. In case they might interest as well. They could be interesting trade if not good investment.
Patience is virtue, not blind patience

[JJAAMMAANN]

So, what's your take Wolf?

Is anything going to happen at all...will the new shell stay Avant Diagnostics, or will it become Amarantus Diagnostics?

The 8K states "Merge into", not "Merge with"...

Will either company or owner prosper? or is it truly a pipe dream to pump both companies?

On January 19, 2016, Avant Diagnostics, Inc. (the "Company") issued a press release announcing it has entered into a non-binding Letter of Intent to merge into, Amarantus Diagnostics, Inc., a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc.

http://www.sec.gov/Archives/edgar/data/1451929/000147793216008294/advx_8k.htm